Kamada KMDA
NASDAQ KMDA
$8.58 -0.11 (-1.32%)
As of: Sep 30, 2026 · 9:45 AM EDT

Kamada (KMDA) Revenue (2012 - 2026)

Updated

Kamada (KMDA) posted Revenue of $54.92 million for the quarter ended Jun 30, 2026, up 22.7% from $44.75 million a year earlier and up 21.4% from the prior quarter.

Analysis

Kamada (KMDA) Revenue (2012 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at Kamada was $191.85 million, up 13.2% year-over-year; for the year ended Dec 31, 2025, it came in at $180.46 million, up 12.1% from the prior year.

  • Annual Revenue has increased for four consecutive years, with a five-year compound annual growth rate of 6.3% (years ended Dec 2020 to Dec 2025).
  • In prior years, Kamada's Revenue was $160.95 million in the year ended Dec 31, 2024 (+12.9%), $142.52 million in the year ended Dec 31, 2023 (+10.2%), $129.34 million in the year ended Dec 31, 2022 (+24.8%) and $103.64 million in the year ended Dec 31, 2021 (-22.2%).
  • The figure for the quarter ended Jun 30, 2026 stands as the highest quarterly Revenue since the quarter ended Sep 30, 2017.
  • On a year-over-year basis, Revenue has increased in each of the last ten quarters, with growth averaging 11.5% over the last eight quarters.
  • The strongest year-over-year quarter for Revenue in the past five years was the quarter ended Jun 30, 2023, with growth of 58.7%; the weakest was the quarter ended Sep 30, 2021, with a decline of 34.8%.
  • According to Business Quant data, Revenue for the three prior quarters was $45.24 million (quarter ended Mar 31, 2026), $44.68 million (quarter ended Dec 31, 2025) and $47.01 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.31 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 16.99 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.38 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.33 Bn
10 Kamada 497.25 Mn 206.31 Mn 22.47 Mn 54.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 54.92 Mn
Mar 31, 2026 45.24 Mn
Dec 31, 2025 44.68 Mn
Sep 30, 2025 47.01 Mn
Jun 30, 2025 44.75 Mn
Mar 31, 2025 44.02 Mn
Dec 31, 2024 39.01 Mn
Sep 30, 2024 41.74 Mn
Jun 30, 2024 42.47 Mn
Mar 31, 2024 37.74 Mn
Dec 31, 2023 36.43 Mn
Sep 30, 2023 37.93 Mn
Jun 30, 2023 37.44 Mn
Mar 31, 2023 30.71 Mn
Dec 31, 2022 45.44 Mn
Sep 30, 2022 32.22 Mn
Jun 30, 2022 23.59 Mn
Mar 31, 2022 28.09 Mn
Dec 31, 2021 31.47 Mn
Sep 30, 2021 23.03 Mn
API Access

Kamada Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=KMDA&period=max&api_key=YOUR_API_KEY